Insulin lispro biosimilar (Genovate Biotechnology)
N/A
Report date: 2025/03/07 17:34:48
Base Information
Drug NameInsulin lispro biosimilar (Genovate Biotechnology)
Drug Alias NameN/A
Classification
Mechanisms of Action
Targets
Therapy Area/IndicationsN/A
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesGenovate Biotechnology Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesGenovate Biotechnology Co Ltd
Inactive CompaniesN/A
Active IndicationsN/A
Inactive IndicationsN/A
Other Information
ATC CodeN/A
Related LinksN/A